Role of adipose tissue for cardiovascular-renal regulation in health and disease

Hormone and Metabolic Research

Volumn 32, Issue 11-12, 2000, Pages 485-499

  Engeli, S ^a   Sharma, A M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Atrial Natriuretic Peptide; Fat Cells; Hypertension; Leptin; Nitric Oxide; Non Esterified Fatty Acids; Obesity; Prostacyclin Adipose Tissue Blood Flow; Renin Angiotensin System

Indexed keywords

ADIPOSE TISSUE; ADIPOSE TISSUE BLOOD FLOW; CARDIOVASCULAR DISEASE; HUMAN; HUMAN CELL; HYPERTENSION; KIDNEY FUNCTION; OBESITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

EID: 0034471739     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978675     Document Type: Review

References (228)

1. Bodymass index mortality in a prospective cohort of U.S. adults
2. Annual deaths attributable to obesity in the United States
3. Regional adiposity and morbidity
4. Close correlation of intra-abdominal fat accumulation to hypertension in obese women
5. Cardiovascular regulation in obesity-induced hypertension
6. The haemodynamics of obesity: A theoretical analysis
7. Diastolic compliance is reduced in obese rabbits
8. Obese hypertensive rabbits develop concentric and eccentric hypertrophy and diastolic filling abnormalities
9. Hypertension, cardiac hypertrophy, and neurohumoral activity in a new animal model of obesity
10. The disease burden associated with overweight and obesity
11. Medical hazards of obesity
12. Obesity and cardiovascular hemodynamic function
13. Blood pressure levels and obesity trends in hypertensive and normotensive Finnish population from 1982 to 1997
14. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
15. Guidelines for the Management of Hypertension
16. Obesity and hypertension
17. Mechanisms of hypertension and kidney disease in obesity
18. Fat cell metabolism: Insulin, fatty acids, and renin
19. Role of sympathetic nervous system and neuropeptides in obesity hypertension
20. Obesity-induced hypertension: New concepts from the emerging biology of obesity
21. Physiology and pathophysiology of the adipose tissue renin-angiotensin system
22. Vascular effects of non-esterified fatty acids: Implications for the cardiovascular risk factor cluster
23. The natriuretic peptide system in obesity-related hypertension: New pathophysiological aspects
24. A review of the microcirculation of adipose tissue: Anatomic, metabolic, and angiogenic perspectives
25. Hemodynamic alterations in hypertensive obese rabbits
26. Hemodynamics of obesity: Influence of pattern of adipose tissue cellularity
27. Obesity-induced hypertension: Renal function and systemic hemodynamics
28. Type of obesity and blood pressure
29. Relation of central hemodynamics to obesity and body fat distribution
30. Central adiposity and hemodynamic functioning at rest and during stress in adolescents
31. Weight gain-induced blood pressure elevation
32. Development of hypertension in a rat model of diet-induced obesity
33. Resting metabolic rate and substrate use in obesity hypertension
34. Role of the sympathetic nervous system during the development of obesity-induced hypertension in rabbits
35. Familial hypertension, insulin, sympathetic activity, and blood pressure elevation
36. Sodium and obesity in the pathogenesis of hypertension
37. Blunted natriuretic response to an acute sodium load in obese hypertensive dogs
38. Salt-regulating hormones in young normotensive obese subjects: Effects of saline load
39. Abnormal pressure natriuresis in the dog model of obesity-induced hypertension
40. Sodium balance and hypertension in obese and fatty rats
41. Altered pressure-natriuresis in obese Zucker rats
42. Mechanisms of abnormal renal sodium handling in obesity hypertension
43. Distribution of renal medullary hyaluronan in lean and obese rabbits
44. Increased hyaluronic acid in the inner renal medulla of obese dogs
45. Renal sympathetic nerve activity is increased in obese Zucker rats
46. Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats
47. Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: Potential role in glomerulosclerosis
48. Massive obesity and the kidney. A morphologic and statistical study
49. Glomerulomegaly and focal segmental glomerulosclerosis associated with obesity and sleepapnea syndrome
50. Renal denervation attenuates the sodium retention and hypertension associated with obesity
51. Renal denervation prevents and reverses hyperinsulinemia-induced hypertension in rats
52. Neural mechanisms in human obesity-related hypertension
53. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects
54. Is there a role for the ob gene product leptin in essential hypertension?
55. High plasma leptin concentrations in hypertensive men but not in hypertensive women
56. Fasting insulin and leptin serum levels are associated with systolic blood pressure independent of percentage body fat and body mass index
57. The obese gene product, leptin: Possible role in obesity-related hypertension in adolescents
58. Plasma leptin level is associated with myocardial wall thickness in hypertensive insulin-resistant men
59. Leptin is associated with increased risk of myocardial infarction
60. Elevated plasma immunoreactive leptin levels preexist in healthy offspring of patients with essential hypertension
61. Plasma leptin levels strongly correlate with plasma renin activity in patients with essential hypertension
62. Relationship between angiotensinogen, leptin and blood pressure levels in young normotensive men
63. Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action
64. Serum immunoreactive-leptin concentrations in normal weight and obese humans
65. Leptin secretion from adipose tissue in women - Relationship to plasma levels and gene expression
66. Hyperleptinemia is more closely associated with adipose cell hypertrophy than with adipose tissue hyperplasia
67. Augmentation of obese (ob) gene expression and leptin secretion in obese spontaneously hypertensive rats (obese SHR or Koletsky rats)
68. Molecular pathology in the obese spontaneous hypertensive Koletsky rat: A model of syndrome X
69. Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats
70. Chronic leptin infusion increases arterial pressure
71. Receptor-mediated regional sympathetic nerve activation by leptin
72. Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice
73. Pathophysiological role of leptin in obesity-related hypertension
74. Human leptin deficiency caused by a missense mutation: Multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects
75. Plasma leptin concentrations and cardiac autonomic nervous system in healthy subjects with different body weights
76. Pivotal role of nitric oxide in the control of blood pressure after leptin administration
77. Sympathetic and cardiorenal actions of leptin
78. A comparison of the natriuretic/diuretic effects of rat vs. human leptin in the rat
79. Effects of renal denervation on the sodium excretory actions of leptin in hypertensive rats
80. Regulation of lipolysis in humans. Pathophysiological modulation in obesity, diabetes, and hyperlipidaemia
81. Obesity hypertension is related more to insulin's fatty acid than glucose action
82. Influence of body fat distribution on free fatty acid metabolism in obesity
83. Catecholamine-induced lipolysis in obesity
84. Regulation of plasma fatty acid metabolism
85. Lowering fatty acids potentiates acute insulin response in first degree relatives of people with type II diabetes
86. The relationship of blood pressure with glucose, insulin, heart rate, free fatty acids and plasma cortisol levels according to degree of obesity in middle-aged men
87. Insulin-resistant lipolysis in abdominally obese hypertensive individuals - Role of the renin-angiotensin system
88. Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism
89. Intralipid enhances alpha1-adrenergic receptor mediated pressor sensitivity
90. Fatty acids enhance vascular alpha-adrenergic sensitivity
91. Mechanisms in the pressor effects of hepatic portal venous fatty acid infusion
92. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation
93. Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production
94. Immunohistochemical and ultrastructural localization of leptin and leptin receptor in human white adipose tissue and differentiating human adipose cells in primary culture
95. Leptin: An essential regulator of lipid metabolism
96. Metabolic effects of leptin on human adipocytes
97. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats
98. Genetics of Cd36 and the clustering of multiple cardiovascular risk factors in spontaneous hypertension
99. Silverstein RLA null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism
100. Insulin resistance and cardiovascular disease
101. Long-chain fatty acids activate calcium channels in ventricular myocytes
102. Lipotoxic heart disease in obese rats: Implications for human obesity
103. Fatty acid regulation of gene expression. Transcriptional and post-transcriptional mechanisms
104. Regulation by fatty acids of angiotensinogen gene expression in preadipose cells
105. Oleic acid and angiotensin II induce a synergistic mitogenic response in vascular smooth muscle cells
106. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents
107. Renin and aldosterone are higher and the hyperinsulinemic effect of salt restriction greater in subjects with risk factors clustering
108. Aldosterone in obesity
109. Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans
110. ACE, angiotensinogen and obesity: A potential pathway leading to hypertension
111. Angiotensinogen levels and obesity in four black populations. ICSHIB Investigators
112. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children
113. Plasma angiotensinogen concentrations in obese patients
114. Central obesity and hypertension: Relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in young obese subjects
115. Gene expressionof angiotensinogen in adipose tissue of obese patients
116. Blood pressure and hormone changes associated with weight reduction in the obese
117. The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients
118. Aldosterone studies in obese patients with hypertension
119. Effect of weight reduction on the renin-aldosterone axis
120. Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women
121. Ambulatory blood pressure and neuroendocrine control after diet-assisted gastric restrictive surgery
122. Angiotensinogen-deficient mice with hypotension
123. Contribution of adipose tissue to circulating angiotensinogen plasma levels
124. Tissue-specific nutritional regulation of angiotensinogen in adipose tissue
125. Consequences of weight cycling in obese spontaneously hypertensive rats
126. Refeeding hypertension in dietary obesity
127. Increased adipose angiotensinogen gene expression in human obesity
128. The association of human adipose angiotensinogen gene expression with abdominal fat distribution in obesity
129. Evidence of AGT and TNF-α secretion by human adipocytes from obese patients
130. Regulation by glucocorticoids of AGT gene expression and secretion in adipose cells
131. Insulin down-regulates angiotensinogen gene expression and angiotensinogen secretion in cultured adipose cells
132. Effects of insulin and glucagon on production of renin substrate by the isolated rat liver
133. Downregulation of the renin-angiotensin system in streptozotocin-diabetic rats
134. Differential regulation of leptin and AGT secretion in rat adipose cells
135. Angiotensinogen gene expression in adipose tissue: Analysis of obese models and hormonal and nutritional control
136. Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells
137. Stimulation of prostacyclin production in isolated rat adipocytes by angiotensin II, vasopressin, and bradykinin: Evidence for two separate mechanisms of prostaglandin synthesis
138. 2 release by angiotensin II
139. Mechanisms contributing to angiotensin II regulation of body weight
140. Angiotensin II in brown adipose tissue from young and adult Zucker obese and lean rats
141. 3H]norepinephrine release from rat interscapular brown adipose tissue
142. Role of angiotensin II in brown adipose thermogenesis during cold acclimation
143. Influence of perivascular adipose tissue on rat aortic smooth muscle responsiveness
144. Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism
145. Regulation of angiotensin II type I receptor mRNA and protein in angiotensin II-induced hypertension
146. Facilitation of sympathetic neurotransmission contributes toangiotensin regulation of body weight
147. Double-blind study of dilevalol and captopril, both in combination with hydrochlorothiazide, in patients with moderate to severe hypertension
148. Converting enzyme inhibition and its withdrawal in spontaneously hypertensive rats
149. Enalapril in essential hypertension: A comparative study with propranolol
150. Metabolic and hemodynamic response to angiotensin II in rat adipose tissue
151. Role of kinins in the acute antihypertensive effect of the converting enzyme inhibitor, captopril
152. Endothelium-mediated vasodilation during ACE inhibition
153. Effect of captopril, losartan, and bradykinin on early steps of insulin action
154. Molecular biology and biochemistry of the natriuretic peptide system. I: Natriuretic peptides
155. Molecular biology and biochemistry of the natriuretic peptide system. II: Natriuretic peptide receptors
156. Natriuretic peptides
157. ANP in regulation of arterial pressure and fluid-electrolyte balance: Lessons from genetic mouse models
158. Transforming growth factor alpha and atrial natriuretic peptide in white adipose tissue depots in rats
159. Localization of atrial natriuretic factor receptors in the mesenteric arterial bed. Comparison with angiotensin II and endothelin receptors
160. Comparative analysis of atrial natriuretic peptide receptor expression in rat tissues
161. Fasting inhibits natriuretic peptides clearance receptor expression in rat adipose tissue
162. Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients
163. Specific potentiation by cyclic AMP of natriuretic peptide-mediated cyclic GMP production in adipose tissue
164. Natriuretic peptides: A new lipolytic pathway in human adipocytes
165. Low calorie diet enhances renal, hemodynamic, and humoral effects of exogenous atrial natriuretic peptide in obese hypertensives
166. Effect of experimental obesity and subsequent weight reduction upon circulating atrial natriuretic peptide
167. Factors regulating the production of prostaglandin E2 and prostacyclin (prostaglandin 12) in rat and human adipocytes
168. Prostacyclin: Its pathogenic role in essential hypertension and the class effect of ACE inhibitors on prostaglandin metabolism
169. Differentiation of preadipose cells: Paracrine role of prostacyclin upon stimulation of adipose cells by angiotensin-II
170. Expression of the two isoforms of prostaglandin endoperoxide synthase (PGHS-1 and PGHS-2) during adipose cell differentiation
171. Prostacyclin production by isolated rat adipocytes: Evidence for cyclic adenosine 3′,5′-monophosphate-dependent and independent mechanisms and for a selective effect of insulin
172. Developmental aspects of the adipose tissue renin-angiotensin system: Therapeutic implications
173. Differential expression of prostaglandin receptor mRNAs during adipose cell differentiation
174. +)-elevating agent
175. Prostacyclin as a potent effector of adipose-cell differentiation
176. Prostacyclin as a critical prostanoid in adipogenesis
177. Prostacyclin IP receptor up-regulates the early expression of C/ EBPbeta and C/EBPdelta in preadipose cells
178. Differential response of preadipocytes and adipocytes to prostacyclin and prostaglandin E2: Physiological implications
179. Evidence for a novel regulatory pathway activated by (carba)prostacyclin in preadipose and adipose cells
180. Modulation of vascular tone and glycerol levels measured by in situ microdialysis in rat adipose tissue
181. Inducible nitric oxide synthase in rat brown adipocytes: Implications for blood flow to brown adipose tissue
182. Mechanism of adipose tissue iNOS induction in endotoxemia
183. A nitric oxide-mediated mechanism regulates lipolysis in human adipose tissue in vivo
184. White adipose tissue nitric oxide synthase: A potential source for NO production
185. Nitric oxide system genes and formation of nitric oxide in human adipose tissue
186. Expression of nitric oxide synthases in subcutaneous adipose tissue of nonobese and obese humans
187. Angiotensin II stimulates synthesis of endothelial nitric oxide synthase
188. New insights into the regulation of inducible nitric oxide synthesis
189. Signalling by cGMP-dependent protein kinases
190. Physiology and pathophysiology of nitric oxide
191. Effects of nitric oxide on proliferation and differentiation of rat brown adipocytes in primary cultures
192. Modulation of white adipose tissue lipolysis by nitric oxide
193. Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent
194. Nitric oxide mediates down regulation of lipoprotein lipase activity induced by tumor necrosis factor-alpha in brown adipocytes
195. Involvement of nitric oxide in noradrenaline-induced increase in blood flow through brown adipose tissue
196. Possible involvement of L-arginine-nitric oxide pathway in modulating regional blood flow to brown adipose tissue of rats
197. Inhibition of nitric oxide generation unmasks vascular dysfunction in insulin-resistant, obese JCR:LA-cp rats
198. Role of L-arginine-nitric oxide pathway in hypertension
199. Nitric oxide synthases: Regulation in disease
200. Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats
201. Peroxisome proliferator-activated receptors in the cardiovascular system
202. Antihypertensive effects of CS-045 treatment in obese Zucker rats
203. Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect
204. Vasodilatory effects of troglitazone improve blood pressure at rest and during mental stress in type 2 diabetes mellitus
205. Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma
206. 15-Deoxy-delta(12,14) prostaglandin J2: A putative endogenous promoter of adipogenesis suppresses the ob gene
207. Impaired postprandial tissue regulation of blood flow in insulin resistance: A determinant of cardiovascular risk?
208. Presynaptic modulation of neurotransmitter release by endogenous angiotensin II in brown adipose tissue
209. In situ assessment of the role of the beta 1-, beta 2- and beta 3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue
210. Role of vascular alpha-2 adrenoceptors in regulating lipid mobilization from human adipose tissue
211. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects
212. Increased obese mRNA expression in omental fat cells from massively obese humans
213. Direct effects of leptin on brown and white adipose tissue
214. Fat cell adrenergic receptors and the control of white and brown fat cell function
215. Adrenoceptor genes in human obesity
216. Insulin receptor binding and insulin action in human fat cells: Effects of obesity and fasting
217. Characterization of human adipocyte adenosine receptors
218. Changes in adenosine A1- and A2-receptor expression during adipose cell differentiation
219. Characterization of NPY receptors controlling lipolysis and leptin secretion in human adipocytes
220. Characterization of the promoter of human adipocyte hormone-sensitive lipase
221. Adipsin/acylation stimulating protein system in human adipocytes: Regulation of triacylglycerol synthesis
222. Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II
223. Evidence for a local renin angiotensin system in primary cultured human preadipocytes
224. Co-expression of renin-angiotensin system genes in human adipose tissue
225. The expression and localisation of the angiotensin-converting enzyme mRNA in human adipose tissue
226. Distribution of angiotensin II receptors in rat and human adipocytes
227. Immunocytochemical localization, binding, and effects of atrial natriuretic peptide in rat adipocytes
228. Expression of natriuretic peptide receptors in human adipose and other tissues